Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ORPH | BMY | AMGN | GSK | GILD |
| Company | Orphazyme A/S ADR | Bristol-Myers Squibb Company | Amgen Inc | Gsk Plc ADR | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 0.9060 | 48.21 | 264.63 | 39.37 | 66.25 |
| High | 0.9571 | 49.05 | 269.38 | 39.76 | 66.83 |
| Low | 0.8457 | 48.12 | 260.68 | 39.37 | 66.16 |
| Last | 0.8700 | 48.93 | 268.93 | 39.75 | 66.76 |
| Change | -0.0200 | +0.63 | +6.18 | +0.48 | +0.60 |
| % Change | -2.25% | +1.30% | +2.35% | +1.22% | +0.91% |
| Volume | 941,400 | 10,303,913 | 3,380,300 | 1,623,882 | 10,656,899 |
| 20-Day Average Volume | 1,980,090 | 11,303,500 | 2,246,435 | 2,930,825 | 6,455,915 |
| Previous Close | 0.8900 | 48.30 | 262.75 | 39.27 | 66.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9128 | 50.85 | 272.56 | 41.23 | 69.90 |
| 20-Day Raw Stochastic | 41.76% | 19.17% | 29.59% | 13.85% | 10.79% |
| 20-Day Relative Strength | 36.52% | 41.16% | 43.95% | 37.41% | 31.30% |
| Weighted Alpha | -87.89 | -28.90 | +7.67 | +9.70 | -24.32 |
| Today's Opinion | 100% Sell | 72% Sell | 56% Sell | 24% Buy | 100% Sell |
| Previous Opinion | 100% Sell | 72% Sell | 56% Sell | 24% Buy | 100% Sell |
| Last Month's Opinion | 100% Sell | 24% Sell | 8% Sell | 80% Buy | 72% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.47% since 03/23/22 | +1.35% since 04/12/24 | +0.62% since 04/12/24 | -2.24% since 04/12/24 | -1.92% since 04/12/24 |
| Low | 0.8275 on 03/29/22 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 39.15 on 04/18/24 | 65.90 on 04/18/24 |
| High | 0.9600 on 03/29/22 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 41.06 on 04/15/24 | 68.46 on 04/15/24 |
| 1-Month | |||||
| %Chg | -28.69% since 02/28/22 | -5.54% since 03/19/24 | -1.03% since 03/19/24 | -6.07% since 03/19/24 | -9.06% since 03/19/24 |
| Low | 0.5101 on 03/14/22 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 39.15 on 04/18/24 | 65.90 on 04/18/24 |
| High | 1.3720 on 03/10/22 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 43.45 on 03/25/24 | 74.28 on 03/21/24 |
| 3-Month | |||||
| %Chg | -67.29% since 12/28/21 | -2.35% since 01/19/24 | -12.63% since 01/19/24 | +0.18% since 01/19/24 | -23.52% since 01/19/24 |
| Low | 0.5101 on 03/14/22 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 38.56 on 01/25/24 | 65.90 on 04/18/24 |
| High | 2.7500 on 01/03/22 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 43.84 on 03/07/24 | 81.06 on 01/25/24 |
| 6-Month | |||||
| %Chg | -79.33% since 09/28/21 | -13.37% since 10/19/23 | -4.16% since 10/19/23 | +12.32% since 10/19/23 | -14.89% since 10/19/23 |
| Low | 0.5101 on 03/14/22 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 33.67 on 11/02/23 | 65.90 on 04/18/24 |
| High | 5.4900 on 10/13/21 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 43.84 on 03/07/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 30,721 | 97,892,464 | 140,812,720 | 81,384,712 | 82,374,304 |
| Shares Outstanding, K | 35,312 | 2,026,759 | 535,919 | 2,072,440 | 1,245,077 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 37,725,000,000 | 27,116,000,000 |
| Annual Net Income | -97,010,000 | 8,025,000,000 | 6,717,000,000 | 6,129,940,000 | 5,665,000,000 |
| Last Quarter Sales | N/A | 11,477,000,000 | 8,196,000,000 | 9,980,060,000 | 7,114,000,000 |
| Last Quarter Net Income | N/A | 1,762,000,000 | 767,000,000 | 433,200,000 | 1,429,000,000 |
| 60-Month Beta | 1.68 | 0.39 | 0.58 | 0.64 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 0.72 on 01/31/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 04/05/22 | 04/25/24 | 05/02/24 | 05/01/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.397 on 02/22/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 02/22/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.38 | 14.16 | 10.29 | 9.96 |